VF
MIST icon

Virtu Financial’s Milestone Pharmaceuticals MIST Stock Holding History

Virtu Financial’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,761
Closed -$29K – 1840
2025
Q2 		$29K Buy
+14,761
New +$19.7K ﹤0.01% 1212
2025
Q1 		– Sell
-71,955
Closed -$170K – 1770
2024
Q4 		$170K Buy
+71,955
New +$124K 0.01% 925
2024
Q1 		– Sell
-18,686
Closed -$31K – 1814
2023
Q4 		$31K Buy
+18,686
New +$50.7K ﹤0.01% 1247
2023
Q3 		– Sell
-11,743
Closed -$33K – 1647
2023
Q2 		$33K Buy
+11,743
New +$44.3K ﹤0.01% 1186
2023
Q1 		– Sell
-15,774
Closed -$62K – 1847
2022
Q4 		$62K Buy
+15,774
New +$83K 0.01% 1044

Other funds holding MIST

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return